TokenPost·
DiaMedica Expects $34.9 Million to Fund Planned Operations Into Q4 2027
The company held $34.9 million in cash, cash equivalents and short-term investments on Sept. 30. A ReMEDy2 interim review is expected in Q1 2027.
More news
- TokenPostAkari Therapeutics, Plc Posts Approximately $4.8 Million Q3 Net Loss
- TokenPostStrategy’s MSCI removal does not force Bitcoin sales, Melker says
- TokenPostLangChain Raises $300 Million at $3 Billion Post-Money Valuation
- TokenPostDempsey Says Crypto Venture Activity Stalled as Talent Focused on AI
- TokenPostSupreme Court Agrees to Hear Robinhood Challenge to IPO Lawsuit
- Crypto BriefingCommerce Secretary Lutnick to testify on chip export controls under pressure